Cardiovascular stents - Biomaterials and Devices for the Circulatory System - page 211

WAKSMAN R, WHITE L, CHAN RC, BASS BG, GEIRLACH L, MN|INTZ GS, SATLER LF, MEHRAN
R, SERRUYS PW, LANSKY AJ, FI TZGERALD P, BHARGAVA B, KENT KM, PICHARD AD and
LEON MB. Intracoronary gamma-radiation therapy after angioplasty inhibits recur-
rence in patients with in-stent restenosis. Circulation 2000b; 101 : 2165-2171.
WAKSMAN R, RAJBABU P, BAFFOUR R, SEABRON R, HELLINGA D and TIO FO. Short term
effects of biocorrodible iron stents in porcine coronary arteries. J Interven Cardiol
2008; 21 : 15-20.
WARDEH AJ, KAY IP, SABATE M, COEN VL, GIJZEL AL, LIGHART JM, DEN BOER A, LEVENDAG
PC, VAN DER GEISSEN WJ, SERRUYS PW et al. Beta particle emitting radioactive stent
implantation: a safety and feasibility study. Circulation 1999; 100 : 1684-1689.
WATAHA JC, LOCKWOOD PE and SCHEDLE A. Effect of silver, copper, mercury and nickel
ions on cellular proliferation during extended, low-dose exposures. J Biomed
Mater Res 2000, 52 : 360-364.
WESSELY R, HAUSTERLEITNER J, MICHAELIS C, JASCHKE B, VOGESER M, MILZ S, BEHNISCH
B, SCHRATZENSTALLER T, RENKE-GLUSZKO M, STÖVER M, WINTERMANTEL E, KASTRATI A
and SCHÖMIG A. Inhibition of neointima formation by a novel drug-eluting stent
system that allows for dose-adjustable, multiple, and on-site stent coating. Arte-
rioscler Thromb Vasc Biol 2005; 25 : 748-753.
WHELAN DM, VAN DER GIESSEN WJ, KRABBENDAM SC, VAN VLIET EA, VERDOUW PD,
SERRUYS PW and VAN BEUSEKOM HM. Biocompatibility of phosphorylcholine coated
stents in normal porcine coronary arteries. Heart 2000 Mar; 83 (3): 338-345.
WIENEKE H, DIRSCH O, SAWITOWSKI T, GU YL, BRAUER H, DAHMEN U, FI SCHER A, WNENDT
S and ERBEL R. Synergistic effects of a novel nanoporous stent coating and tacro-
limus on intima proliferationin rabbits. Catherter Cardiovasc Interv 2003; 60 (3):
408-409.
WINDECKER S and MEIER B. Late coronary stent thrombosis. Circulation 2007; 116 :
1952-1965.
WINDECKER S, MAYER I, DE PASQUALE G, MAIER W, DIRSCH O, DE GROOT P WU YP, NOLL
G, LESKOSEK B, MEIER B, HESS OM, WORKING GROUP ON NOVEL SURFACE COATING OF
BIOMEDICAL DEVICES (SCOL). Stent coating with titanium-nitride-oxide for reduc-
tion of neointimal hyperplasia. Circulation 2001; 104 (8): 928-933.
WINDECKER S, SIMON R, LINS M, KLAUSS V, EBERLI FR, ROFFI M, PEDRAZZINI G, MOCCETTI
T, WENAWESER P, TOGNI M, TÜLLER D, ZBINDEN R, SEILER C, MEHILLI J, KASTRATI A
MEIER B and HESS OM. Randomized comparison of a titanium-nitride oxide-coated
stent with stainless steel stent for coronary revascularisation: the TiNOX trial.
Circulation 2005; 111 (20); 2617-2622.
WINDECKER S, SERRUYS PW, WANDEL S, BUSZMAN P, TRZNADEL S, LINKE A, LENK K, ISCH-
INGER T, KLAUSS V, ERBERLI F, CORTI R, WIJNS W, MORICE MC, DI MARIO C, DAVIES S,
VAN GEUNS RJ, EERDMANS P, VAN ES G-A, MEIER B and JÜNI P. Biolimus-emulating
stent with biodegradable polymer versus sirolimus-eluting stent with durable
polymer for coronary revascularisation (LEADERS): a randomised non-
inferiority trial. Lancet 2008; 372 : 1163-1173.
WÖHRLE J, NUSSER T, LANGENWALDER S, HOMBACH V and KOCKS M. Carbon-coated
stents in patients with acute coronary syndromes. Clin Cardiol 2009; 32 (6): E1E6.
YANG P, CHEN JY, LENG YX, SUN H, HUANG N, CHU PK. Effect of annealing on structure
and biomedical properties of amorphous hydrogenated carbon fi lms. Surface
Coatings Technol 2004; 186 : 125-130.

￿ ￿ ￿ ￿ ￿